Curry International Tuberculosis Center (CITC)

Location(s): Ethiopia; Kenya; Tanzania; Zimbabwe; Botswana; Namibia; China; India; Nepal; Indonesia; Thailand; Mexico; Caribbean

Description

The Curry International Tuberculosis Center (CITC) creates, enhances, and disseminates state-of-the-art resources and models of excellence and performs research to control and eliminate tuberculosis in the United States and internationally.

Active Projects: 20

Project
Investigator Topics Location Start End
ATS Implementation Guide and Training Modules Philip Hopewell, MD Tuberculosis, Training and Capacity Building Kenya; Tanzania; China; India; Nepal; Indonesia; Mexico
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD HIV/AIDS, Tuberculosis, Pediatrics, Epidemiology and Surveillance Uganda
Diabetes and Tuberculosis in Brazilian slum settings Jayant Rajan, MD Tuberculosis, Noncommunicable and/or Chronic Disease, Diabetes, Occupational and Environmental Disease, Access or Barriers to Care, Stigma and Discrimination Brazil
Effects of Air Pollution on Childhood Tuberculosis in Viet Nam Robert Blount, MD Tuberculosis, Pediatrics Viet Nam
From Poverty to Cure: Overcoming Socioeconomic Barriers to Tuberculosis Care Priya Shete, MD Tuberculosis, Implementation and Behavioral Science Uganda
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy Michael J. Reid, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening United States
Improving the molecular diagnosis of drug resistant tuberculosis Midori Kato-Maeda, MD Tuberculosis, Drug and Diagnostics Development Philippines
Novel Biomarkers to Shorten TB Treatment Rada Savic, PhD Tuberculosis United States
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis South Africa
Optimal MDR treatment in children Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis South Africa
Overcoming socioeconomic barriers to TB care: the case for social protection Priya Shete, MD Tuberculosis, Engagement in Care, Treatment Adherence Brazil
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden Diane Havlir, MD HIV/AIDS, Tuberculosis Uganda
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development Uganda
TB Surrogate Markers for Assessing Response to Treatment (TB SMART Study) Payam Nahid, MD, MPH Tuberculosis, Drug and Diagnostics Development United States
The impact of TB co-infection on the reservoir of persistent HIV in vivo Mike McCune, MD, PhD HIV/AIDS, Tuberculosis, Immunology Uganda
Tuberculosis contact tracing in resource poor settings Elizabeth Fair, PhD, MPH Tuberculosis, Epidemiology and Surveillance Tanzania; Indonesia
Tuberculosis Epidemiologic Studies George Rutherford, MD Tuberculosis, Epidemiology and Surveillance United States
Tuberculosis Trial Consortium Payam Nahid, MD, MPH Tuberculosis Kenya; Uganda; South Africa; China; Viet Nam; Brazil; Peru
UN Special Envoy for Tuberculosis: Strategic Priorities Eric Goosby, MD Tuberculosis, Health Economics and Effectiveness, Policy and Standards of Care Ethiopia; Kenya; Mozambique; Tanzania; Zambia; Zimbabwe; Angola; Central African Republic; Congo (Kinshasa); Congo (Brazzaville); Lesotho; South Africa; Liberia; Nigeria; Sierra Leone; China; North Korea; Bangladesh; India; Pakistan; Cambodia; Indonesia; Viet Nam; Myanmar; Thailand; Philippines; Russia; Brazil; Papua New Guinea
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal Judith Hahn, PhD, MD HIV/AIDS, Tuberculosis, Substance Abuse Uganda

Archived Projects: 135

Project
Investigator Topics Location Start End Link to delete content
A Novel Proteomic Approach to Tuberculosis Biomarker Discovery using Human Exosomes Tuberculosis United States
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance United States
Accelerating and Intensifying Tuberculosis Case Finding in Uganda Tuberculosis, Residencies, Fellowships, and Postdoctoral Training Uganda
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne Luetkemeyer, MD HIV/AIDS, Tuberculosis United States
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD HIV/AIDS, Tuberculosis United States
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD HIV/AIDS, Tuberculosis United States
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Diane Havlir, MD HIV/AIDS, Tuberculosis United States
Automated smear-positive tuberculosis diagnosis Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development United States
Biostatistical analysis of Mycobacterium Tuberculosis Biomarkers for Diagnosis and Cure Rada Savic, PhD Tuberculosis, Drug and Diagnostics Development United States
Capacity Building for Management of First Line Drug Resistant TB in Tanzania Elizabeth Fair, PhD, MPH Tuberculosis, Training and Capacity Building Tanzania
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay Anne Luetkemeyer, MD Tuberculosis Uganda; United States
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD Tuberculosis, Pediatrics Uganda
Clinical and Public Health Impact of Automated Nucleic Acid Testing (Cepheid GeneXpert) to Rule-out Tuberculosis in San Francisco Tuberculosis United States
Comparative Effectiveness of Rapid Diagnostics for Tuberculosis in Uganda Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance Uganda
Conducting Infection Control Assessment and Developing Educational Materials for Mexico Philip Hopewell, MD Tuberculosis Mexico
Coordination of the Development of Tuberculosis Contact Investigation Policy Philip Hopewell, MD Tuberculosis, Policy and Standards of Care United States
Core Prevention and Control Project Philip Hopewell, MD Tuberculosis United States
Core Requirements: Tuberculosis Epidemiologic Studies Consortium Elizabeth Fair, PhD, MPH Tuberculosis United States
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis United States
Determination of the M. tuberculosis proteome interaction map (iMAP) during persistence Tuberculosis United States
Development of an Integrated Social Franchising/ Health Co-op Model to Address TB and HIV among Poor in Sub-Saharan Africa Dominic Montagu, DrPH HIV/AIDS, Tuberculosis, Health Economics and Effectiveness Ethiopia; Malawi; Mozambique; Rwanda; Uganda; Tanzania; Cameroon; Burkina Faso; Nigeria
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages Tuberculosis, Immunology United States
Economic Evaluation of Drone Observed Therapy compared to Directly Observed Treatment Short Course for treatment of Drug sensitive tuberculosis in remote Madagascar Lulua Bahrainwala, MS Health Economics and Effectiveness, Access or Barriers to Care Madagascar
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. Tuberculosis Philip Hopewell, MD Tuberculosis United States
Effectiveness of QuantiFERON-TB Gold (QFT-G) in Contact Tracing Elizabeth Fair, PhD, MPH Tuberculosis, Drug and Diagnostics Development Tanzania
Evaluation of interferon Gamma Release Assays in Overseas Immigration Examination of Children in Moderate and high Burden Countries Elizabeth Fair, PhD, MPH Tuberculosis, Pediatrics United States
Evaluation of Novel Tuberculosis Screening Strategies for People living with HIV Christina Yoon, MD, MPH HIV/AIDS, Tuberculosis Uganda
Evaluation of Point-of-Care C-reactive Protein Assay as a Serial Screening Tool for Active Tuberculosis among People Living with HIV in Uganda Paul Park, MS Tuberculosis Uganda
Evaluation of Smear Microscopy Methods Philip Hopewell, MD Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development United States
Evidence Reviews required for the revision of the WHO guidance on the treatment of TB. Payam Nahid, MD, MPH Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development Viet Nam
Exosomes as Biomarkers for Tuberculosis Tuberculosis United States
Exploring the role of a novel, polymorphic protein family in M. tuberculosis pathogenesis Tuberculosis, Immunology United States
FIND Xpert MTB assay collaboration at Mulago Hospital Laurence Huang, MD Tuberculosis Uganda
Fitness Cost and Compensation in Quinolone-Resistant Mycobacterium tuberculosis Midori Kato-Maeda, MD Tuberculosis United States
Frontloaded Sputum Microscopy Tuberculosis United States
Health Education Videos for Tuberculosis Management in Remote Madagascar Hailey Reeves, MS Tuberculosis, Patient and Peer Education Madagascar
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD HIV/AIDS, Tuberculosis Uganda; South Africa
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD HIV/AIDS, Tuberculosis Uganda; South Africa
HQHIV1003203 Philip Hopewell, MD HIV/AIDS, Tuberculosis United States
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients Adithya Cattamanchi, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development Uganda
Impact of Pregnancy on Tuberculosis Rada Savic, PhD Tuberculosis, Women's Health, Labor and Delivery, Newborn and Infant Health India
Impact of the Number of Contacts on the Transmission of Tuberculosis - a Molecular Epidemiologic Study Payam Nahid, MD, MPH Tuberculosis, Epidemiology and Surveillance Viet Nam
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings John Metcalfe, MD HIV/AIDS, Tuberculosis Zimbabwe
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance Rada Savic, PhD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development United States
Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis in Adults Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development Uganda; Tanzania; Zambia; South Africa; China; India; Iran; Turkey; Bulgaria
Interplay of Strain and Ethnicity in the Immune Response to M. tuberculosis Payam Nahid, MD, MPH Tuberculosis United States
Investigation of Indoor Solid Fuel and Kerosene Use as Tuberculosis Risk Factors Philip Hopewell, MD Tuberculosis Nepal
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection Rada Savic, PhD Tuberculosis United States
Leukopheresis Testing Payam Nahid, MD, MPH Tuberculosis United States
M tuberculosis Cells from Patients with Tuberculosis Midori Kato-Maeda, MD Tuberculosis Tanzania; Zimbabwe; Panama
Master Agreement: Tuberculosis Epidemiologic Studies Consortium Philip Hopewell, MD Tuberculosis United States
Master Agreement: Tuberculosis Indefinite Quantity Contract (TB IQC) Philip Hopewell, MD Tuberculosis United States
Measuring TB Drugs in Hair as a Tool to Monitor Adherence, Exposure and Response Monica Gandhi, MD, MPH Treatment Adherence United States
Mechanism-Based Integrative Pharmacology Model for Tuberculosis Rada Savic, PhD Tuberculosis, Pharmacology and Drug Treatment United States
Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda Adithya Cattamanchi, MD Tuberculosis, Epidemiology and Surveillance Uganda
Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda Tuberculosis, Implementation and Behavioral Science Uganda
Mobile Phone Platform for Genomic Disease Detection Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Genetics Viet Nam
Model Tuberculosis Education and Training Center Philip Hopewell, MD Tuberculosis, Training and Capacity Building United States
Modeling the Reproducibility of Blood Assays for TB Infection Adithya Cattamanchi, MD Tuberculosis United States
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda Gabriel Chamie, MD HIV/AIDS, Tuberculosis, Epidemiology and Surveillance Uganda
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) George Rutherford, MD Tuberculosis, Epidemiology and Surveillance Mozambique
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) George Rutherford, MD HIV/AIDS, Tuberculosis Mozambique
Multiscale System Pharmacology Disease Platform for Tuberculosis Rada Savic, PhD Tuberculosis United States
Nonlinear Mixed Effects Modeling of Rifapentine in Children Rada Savic, PhD Tuberculosis, Pediatrics Kenya; South Africa; China; Viet Nam; Peru; United States
Nonlinear Mixed Effects Modeling of Rifapentine Pharmacokinetics Rada Savic, PhD Tuberculosis, Pharmacology and Drug Treatment Uganda
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB in Vivo Payam Nahid, MD, MPH Tuberculosis, Drug and Diagnostics Development United States
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo Payam Nahid, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development United States
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development Uganda
Novel Techniques for the Detections of Pediatric Tuberculosis in Ethiopia Caryn Bern, MD, MPH Tuberculosis, Pediatrics Ethiopia
Novel Technologies to Increase the Accessibility and Accuracy of Tuberculosis Diagnostic Services in Hanoi Province, Vietnam Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development Viet Nam
Office of the UN Special Envoy for Tuberculosis Eric Goosby, MD Tuberculosis, Policy and Standards of Care Burundi; Comoros; Djibouti; Eritrea; Ethiopia; Kenya; Madagascar; Malawi; Mauritius; Mozambique; Rwanda; Seychelles; Somalia; South Sudan; Uganda; Tanzania; Zambia; Zimbabwe; Angola; Cameroon; Central African Republic; Chad; Congo (Kinshasa); Congo (Brazzaville); Equatorial Guinea; Gabon; Sao Tome and Principe; Algeria; Egypt; Libya; Morocco; Sudan; Tunisia; Western Sahara; Botswana; Lesotho; Namibia; South Africa; Swaziland; Benin; Burkina Faso; Cape Verde; Ivory Coast; Gambia; Ghana; Guinea; Guinea-Bissau; Liberia; Mali; Mauritania; Niger; Nigeria; Senegal; Sierra Leone; Togo; Central Asia; Kazakhstan; Kyrgyzstan; Tajikistan; Turkmenistan; Uzbekistan; China; Hong Kong S.A.R., China; North Korea; South Korea; Macao S.A.R., China; Mongolia; Afghanistan; Bangladesh; Bhutan; India; Iran; Maldives; Nepal; Sri Lanka; Brunei; Cambodia; Indonesia; Viet Nam; Laos; Malaysia; Myanmar; Singapore; Thailand; Timor-Leste; Philippines; Armenia; Azerbaijan; Bahrain; Cyprus; Georgia; Iraq; Israel; Jordan; Kuwait; Lebanon; Oman; Palestinian Territory; Qatar; Saudi Arabia; Syria; Turkey; United Arab Emirates; Yemen; Albania; Andorra; Austria; Belarus; Belgium; Bosnia and Herzegovina; Bulgaria; Croatia; Czech Republic; Denmark; Estonia; Finland; France; Germany; Greece; Hungary; Iceland; Ireland; Italy; Jersey; Kosovo; Latvia; Liechtenstein; Lithuania; Luxembourg; Macedonia; Malta; Moldova; Monaco; Montenegro; Netherlands; Norway; Poland; Portugal; Romania; Russia; San Marino; Serbia; Slovakia; Slovenia; Spain; Sweden; Switzerland; Ukraine; United Kingdom; Belize; Costa Rica; El Salvador; Guatemala; Honduras; Mexico; Nicaragua; Panama; Bolivia; Brazil; Chile; Colombia; Ecuador; French Guiana; Guyana; Paraguay; Peru; Suriname; Uruguay; Venezuela; Caribbean; Anguilla; Turks and Caicos Islands; Antigua and Barbuda; Aruba; Bahamas; Barbados; Cayman Islands; Cuba; Dominica; Dominican Republic; Grenada; Guadeloupe; Haiti; Jamaica; Martinique; Puerto Rico; Saint Kitts and Nevis; Saint Lucia; Saint Vincent and the Grenadines; Trinidad and Tobago; Bermuda; Canada; Greenland; United States; U.S. Virgin Islands; American Samoa; Northern Mariana Islands; Australia; Cook Islands; Guam; French Polynesia; Fiji; Kiribati; Marshall Islands; Micronesia; Nauru; New Zealand; Niue; Palau; Papua New Guinea; Samoa; Solomon Islands; Tokelau; Tonga; Tuvalu; Vanuatu
Operations Research Training Curriculum for Tuberculosis Control Lisa Chen, MD Tuberculosis United States
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans HIV/AIDS Uganda
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans HIV/AIDS Uganda
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans HIV/AIDS, Tuberculosis, Drug and Diagnostics Development Uganda
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis Tuberculosis, Immunology United States
Point-of-care C-reactive protein-based tuberculosis screening among people living with HIV: planning a comparative effectiveness trial Christina Yoon, MD, MPH HIV/AIDS, Tuberculosis United States
Population-Based Molecular Epidemiology of Tuberculosis Philip Hopewell, MD Tuberculosis United States
Population-Based Molecular Epidemiology of Tuberculosis in San Francisco Philip Hopewell, MD Tuberculosis, Epidemiology and Surveillance United States
Prevalence of baseline and longitudinal heteroresistant M. tuberculosis and association with patient-important outcomes John Metcalfe, MD Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis United States
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President's Emergency Plan Timothy Lane, PhD, MPH HIV/AIDS, Tuberculosis, Access or Barriers to Care, Stigma and Discrimination South Africa
Quantiferon+Pamp Payam Nahid, MD, MPH Tuberculosis
Real-Time Reagent-Free Noninvasive Diagnosis of Tuberculosis Payam Nahid, MD, MPH Tuberculosis United States
Regional Capacity Building in Low Incidence Areas Philip Hopewell, MD Tuberculosis, Epidemiology and Surveillance, Engagement in Care United States
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD Tuberculosis, Training and Capacity Building United States
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD Tuberculosis, Training and Capacity Building United States
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD Tuberculosis, Training and Capacity Building United States
Regional Training and Medical Consultation Center Philip Hopewell, MD Training and Capacity Building United States
Regulation of ESX-1 secretion and its role in M. tuberculosis virulence Tuberculosis United States
Role of MmpL Transporters in M. Tuberculosis Virulence Tuberculosis United States
Secretion of Virulence Factors by Mycobacterium tuberculosis Infectious Disease, HIV/AIDS, Tuberculosis, Genetics United States
Sputum M. tuberculosis DNA Kinetics during TB Treatment in Patients with HIV HIV/AIDS, Tuberculosis Uganda
Sputum Processing Methods Tuberculosis, Drug and Diagnostics Development Uganda
Streamlined TB Diagnosis Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development Uganda
Structural and functional studies of M. tuberculosis type VII secretion Oren Rosenberg, MD, PhD Tuberculosis United States
Structural Genomics of Persistence Targets from M. Tuberculosis Tuberculosis United States
Surveilling the syndemic: Assessment of an integrated tuberculosis and HIV pilot surveillance system in Haiti Kristiana Dhillon, MS HIV/AIDS, Tuberculosis Haiti
Systematic Review Series on "Antibody and Antigen Detection for the Immunodiagnosis of Tuberculosis" Philip Hopewell, MD Tuberculosis, Immunology, Systematic Reviews and Guideline Development United States
Systematic Review Series: Non-commercial antibody detection for the dx of pulmonary TB Payam Nahid, MD, MPH Tuberculosis, Systematic Reviews and Guideline Development United States
Systematic Reviews of the Scientific Bases of Antituberculosis Chemotherapy ("Dogma" Review) Philip Hopewell, MD Tuberculosis, Systematic Reviews and Guideline Development United States
T-cell Epitope Contract Payam Nahid, MD, MPH United States
Targeted Behavioral Incentives for Improving Tuberculosis (TB) Diagnostic Evaluation Outcomes Priya Shete, MD HIV/AIDS, Tuberculosis Uganda
Targeted Testing and Treatment of Latent TB Infection Philip Hopewell, MD Tuberculosis United States
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment United States
Task Order #22 Assessing the Integration of Social Network Analysis into Tuberculosis Contact Investigation Practice Philip Hopewell, MD Tuberculosis, Epidemiology and Surveillance United States
TB Diagnosis Technology Adithya Cattamanchi, MD Tuberculosis United States
TB Guideline Observation and Adherence in Low Income Countries (TB GOAL) Adithya Cattamanchi, MD Tuberculosis, Systematic Reviews and Guideline Development Uganda
TB Physician Services Payam Nahid, MD, MPH Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science United States
TB Physician Services Payam Nahid, MD, MPH Tuberculosis United States
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis United States
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science United States
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis United States
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis United States
TB Surrogate Markers for Assessing Response to Treatment (TB SMART Study) Payam Nahid, MD, MPH Tuberculosis United States
TB TO 2015 Philip Hopewell, MD Tuberculosis Ethiopia; Kenya; Tanzania; Botswana; China; India; Nepal; Indonesia; Thailand; Mexico
TBRU: Tuberculosis Research Unit, Case Western Reserve University Philip Hopewell, MD Tuberculosis, Training and Capacity Building United States
Technical Assistance: The National Tuberculosis and Leprosy Control Program: MDR/XDR TB Curry International Tuberculosis Center University of California, San Francisco Philip Hopewell, MD Tuberculosis Uganda
To carry out re-analysis of data from 5 studies on use Loop-mediated Isothermal Amplication (TB-Lamp) technology for rapid TB diagnostics, stratification of results and reporting Adithya Cattamanchi, MD Tuberculosis, Systematic Reviews and Guideline Development Madagascar; Malawi; Uganda; South Africa; Ivory Coast; India; Viet Nam
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. Laurence Huang, MD Tuberculosis United States
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis Laurence Huang, MD HIV/AIDS, Tuberculosis Uganda
Tuberculosis Epidemiologic Studies Consortium George Rutherford, MD Tuberculosis United States
Tuberculosis Epidemiologic Studies Consortium George Rutherford, MD Tuberculosis United States
Tuberculosis Epidemiologic Studies Consortium George Rutherford, MD Tuberculosis, Epidemiology and Surveillance United States
Tuberculosis Epidemiologic Studies Consortium Project George Rutherford, MD Tuberculosis United States
Tuberculosis Epidemiology and Novel Transmission Routes in Rural Tanzania Philip Hopewell, MD Tuberculosis, Epidemiology and Surveillance Tanzania
Tuberculosis Free California George Rutherford, MD Tuberculosis United States
Tuberculosis guidelines and best practices internationally Sarah Royce, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis Cambodia
Tuberculosis Risk Reduction Project George Rutherford, MD Tuberculosis, Systematic Reviews and Guideline Development, Epidemiology and Surveillance United States
Tuberculosis Risk Reduction Project George Rutherford, MD Tuberculosis, Implementation and Behavioral Science, Risk Reduction and Prevention United States
Tuberculosis Training Scholarships (TBTS) Philip Hopewell, MD Tuberculosis, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training United States
Tuberculosis Trials Consortium (TBTC) Payam Nahid, MD, MPH Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment Kenya; Uganda; South Africa; China; Viet Nam; Peru
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians Uganda
UCSF-FIND Uganda Project Laurence Huang, MD Tuberculosis, Drug and Diagnostics Development Uganda
Uncovering How Mycobacterium Tuberculosis Utilizes a Novel Protein Secretion System to Manipulate Host Response During Infection Tuberculosis United States
Utility of Contact Investigation of Drug Susceptible and Resistant Tuberculosis in Tanzania Elizabeth Fair, PhD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Epidemiology and Surveillance Tanzania